These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38594913)

  • 21. The impact of ultrasound-based antenatal screening strategies to detect vasa praevia in the United Kingdom: An exploratory study using decision analytic modelling methods.
    Ruban-Fell B; Attilakos G; Haskins-Coulter T; Hyde C; Kusel J; Mackie A; Rivero-Arias O; Thilaganathan B; Thomson N; Visintin C; Marshall J
    PLoS One; 2022; 17(12):e0279229. PubMed ID: 36538562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of vasa previa across gestation using a screening protocol.
    Rebarber A; Dolin C; Fox NS; Klauser CK; Saltzman DH; Roman AS
    J Ultrasound Med; 2014 Jan; 33(1):141-7. PubMed ID: 24371109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasa Previa.
    Oyelese Y; Javinani A; Shamshirsaz AA
    Obstet Gynecol; 2023 Sep; 142(3):503-518. PubMed ID: 37590981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test characteristics of placental location screening by transabdominal ultrasound at 18-20 weeks.
    Olive EC; Roberts CL; Nassar N; Algert CS
    Ultrasound Obstet Gynecol; 2006 Dec; 28(7):944-9. PubMed ID: 17121427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of vasa praevia: a systematic review and meta-analysis.
    Zhang W; Giacchino T; Chanyarungrojn PA; Ionescu O; Akolekar R
    BMJ Open; 2023 Sep; 13(9):e075245. PubMed ID: 37730391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Velamentous cord insertion: results from a rapid review of incidence, risk factors, adverse outcomes and screening.
    Buchanan-Hughes A; Bobrowska A; Visintin C; Attilakos G; Marshall J
    Syst Rev; 2020 Jun; 9(1):147. PubMed ID: 32576295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review.
    Jauniaux E; Melcer Y; Maymon R
    Am J Obstet Gynecol; 2017 Jun; 216(6):568-575. PubMed ID: 28153653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. #37: Diagnosis and management of vasa previa.
    ; Sinkey RG; Odibo AO; Dashe JS
    Am J Obstet Gynecol; 2015 Nov; 213(5):615-9. PubMed ID: 26292048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Third trimester fetoscopic laser ablation of type II vasa previa.
    Chmait RH; Chavira E; Kontopoulos EV; Quintero RA
    J Matern Fetal Neonatal Med; 2010 May; 23(5):459-62. PubMed ID: 19637106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized management of vasa previa and neonatal outcomes.
    Saji S; Hasegawa J; Oyelese Y; Furuya N; Homma C; Nishimura Y; Nakamura M; Suzuki N
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2680-2685. PubMed ID: 37621145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasa previa: when antenatal diagnosis can change fetal prognosis.
    Sutera M; Garofalo A; Pilloni E; Parisi S; Alemanno MG; Menato G; Sciarrone A; Viora E
    J Perinat Med; 2021 Sep; 49(7):915-922. PubMed ID: 33939903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of a novel "Type 3" vasa previa: case series at a single center.
    Kamijo K; Miyamoto T; Ando H; Tanaka Y; Kikuchi N; Shinagawa M; Yamada S; Asaka R; Fuseya C; Ohira S; Shiozawa T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7730-7736. PubMed ID: 34372741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline No. 439: Diagnosis and Management of Vasa Previa.
    Jain V; Gagnon R
    J Obstet Gynaecol Can; 2023 Jul; 45(7):506-518. PubMed ID: 37209787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasa previa is not infrequent.
    Hasegawa J; Nakamura M; Ichizuka K; Matsuoka R; Sekizawa A; Okai T
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2795-6. PubMed ID: 22839499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis and management of vasa previa: a 6-year review.
    Kanda E; Matsuda Y; Kamitomo M; Maeda T; Mihara K; Hatae M
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1391-6. PubMed ID: 21599804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and causes of perinatal death in prenatally diagnosed vasa previa: a systematic review and meta-analysis.
    Conyers S; Oyelese Y; Javinani A; Jamali M; Zargarzadeh N; Akolekar R; Hasegawa J; Melcer Y; Maymon R; Bronsteen R; Roman A; Shamshirsaz AA
    Am J Obstet Gynecol; 2024 Jan; 230(1):58-65. PubMed ID: 37321285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of point-of-care ultrasound and routine third trimester ultrasound on undiagnosed breech presentation and perinatal outcomes: An observational multicentre cohort study.
    Knights S; Prasad S; Kalafat E; Dadali A; Sizer P; Harlow F; Khalil A
    PLoS Med; 2023 Apr; 20(4):e1004192. PubMed ID: 37023211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasa previa screening strategies: decision and cost-effectiveness analysis.
    Sinkey RG; Odibo AO
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):522-529. PubMed ID: 29786153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.